Tiny nanoparticles laced with the chemotherapy drug docetaxel successfully shrank human prostate tumors in mice, while leaving healthy cells unharmed, scientists at Massachusetts Institute of Technology and Brigham and Women's Hospital report. Tests in larger animals and humans are still are needed, the researchers said.

Full Story:

Related Summaries